NVO · Novo Nordisk A S · Fails to Deliver
Market Cap
$192.00B
Shares
4.42B
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-26 | 12,219 | $48.66 | $594,577 |
| 2026-08-25 | 2,196 | $46.92 | $103,036 |
| 2026-08-24 | 93,181 | $46.74 | $4,355,280 |
| 2026-08-21 | 39,982 | $46.14 | $1,844,769 |
| 2026-08-18 | 393,200 | $44.88 | $17,646,816 |
| 2026-08-17 | 637,798 | $45.89 | $29,268,550 |
| 2026-08-10 | 5,998 | $47.26 | $283,465 |
| 2026-08-06 | 11,101 | $44.53 | $494,328 |
| 2026-08-03 | 500 | $47.08 | $23,540 |
| 2026-07-30 | 11,943 | $51.58 | $616,020 |
| 2026-07-28 | 13,676 | $49.67 | $679,287 |
| 2026-07-24 | 2,145 | $48.18 | $103,346 |
| 2026-07-22 | 2,865 | $49.38 | $141,474 |
| 2026-07-21 | 330 | $49.61 | $16,371 |
| 2026-07-17 | 2,716 | $51.48 | $139,820 |
| 2026-07-16 | 5,957 | $50.56 | $301,186 |
| 2026-07-14 | 27,397 | $49.28 | $1,350,124 |
| 2026-07-13 | 2,279 | $49.48 | $112,765 |
| 2026-07-10 | 260 | $48.88 | $12,709 |
| 2026-07-09 | 446 | $48.89 | $21,805 |
| 2026-07-08 | 1,945 | $49.64 | $96,550 |
| 2026-07-07 | 12,083 | $49.26 | $595,209 |
| 2026-07-06 | 1,376 | $50.43 | $69,392 |
| 2026-07-01 | 477 | $47.94 | $22,867 |
| 2026-06-30 | 2,305 | $48.34 | $111,424 |
| 2026-06-29 | 5,400 | $48.07 | $259,578 |
| 2026-06-26 | 8,665 | $47.64 | $412,801 |
| 2026-06-25 | 20,613 | $47.41 | $977,262 |
| 2026-06-24 | 48,411 | $47.42 | $2,295,650 |
| 2026-06-23 | 6,151 | $45.88 | $282,208 |
| 2026-06-18 | 5,353 | $43.52 | $232,963 |
Showing 1–31 of 31 settlements
Key facts
CIK
353278
CUSIP
670100205
13F (30d)
32 filings
27 filers
Visit website
Investor relations